Croissance Clinical Research is a full-service Contract Research Organization (CRO) in the global clinical research industry. Since its establishment in 2011, CCR has provided comprehensive clinical research services to pharmaceutical, biotechnology, and medical device companies. The organization is committed to delivering high-quality, ethical, and cost-effective solutions that accelerate the development of safe and effective therapeutics, vaccines and medical devices. CCR specializes in managing Phase I–IV clinical trials, including Post-Marketing Surveillance (PMS), Post-Marketing Observational Studies (PMOS), Investigator-Initiated Studies (IIS), and epidemiological research.